Lutisone ointment: Each gram of Lutisone ointment contains Fluticasone Propionate BP 50 micrograms.
Lutisone ointment contains Fluticasone Propionate, a synthetic trifluorinated corticosteroid, for topical dermatologic use. It has anti-inflammatory, antipruritic, and vasoconstrictive properties.
Lutisone (Fluticasone Propionate) ointment is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Dosage & Administration
Apply a thin film of Lutisone (Fluticasone Propionate) ointment to the affected skin areas twice daily. Rub in gently.
The adverse reactions of Fluticasone Propionate ointment are usually mild, self-limiting, and consist primarily of pruritus, burning, hypertrichosis, increased erythema, hives, irritation, and lightheadedness. Each of these events occurred individually in less than 1% of patients. The following additional local adverse reactions have been reported infrequently with Fluticasone Propionate ointment - dryness, folliculitis, acneiform, eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae, and miliaria.
Fluticasone Propionate ointment may cause local cutaneous adverse reactions. If irritation develops, Fluticasone Propionate ointment should be discontinued. Fluticasone Propionate ointment should not be used in the presence of preexisting skin atrophy and should not be used where infection is present at the treatment site. This should not be used in the treatment of rosacea and perioral dermatitis.
Fluticasone Propionate ointment is contraindicated in those patients with a history of hypersensitivity to any of the components in the preparation.
Use in Pregnancy & Lactation
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Fluticasone Propionate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
It is not known whether topical administration of Fluticasone Propionate could result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when Fluticasone Propionate ointment is administered to a lactating woman.
Safety and effectiveness in pediatric patients below 4 years of age have not been established.
Topically applied Fluticasone Propionate ointment can be absorbed in sufficient amounts to produce systemic effects.
Protect from light and moisture.
Store at a temperature not exceeding 30°C.
Lutisone ointment: Each tube contains 10 gm ointment.